- Year 2000 Lynk Biotechnologies, spun off from National University of Singapore (NUS) with ~S$1 million investment from angel investors.
|
- Year 2002 Launch of Biolyn Hair Serum.
|
- Year 2003 Product Rights of Biolyn Hair Serum transferred to Lo Hong Kar (HK).
|
- Year 2003 Launch of MediLynk Transdermal Glucosamine Cream (TGC) (for joint injury).
|
- Year 2004 Launch of MediLynk Transdermal Glucosamine Cream Plus Capsaicin.
|
- Year 2004 Patent on " Novel Ligands And Methods For Preparing The Same" granted
in singapore.
|
- Year 2004 Incorporation of MediLynk as a subsidiary with S$2.5 million investment from Whiterock Investment.
|
- Year 2005 Development of trans-epidermal SportsLynk Pain & Itch relieving cream.
|
- Year 2005 Sucessful completion of Phase I Clinical Trial For MediLynk TGC at the Singapore Changi Hospital.
|
- Year 2005 Investment of S$6 million into Lynk by a group of private investors led by Mr. Lim Kim Hai.
|
- Year 2005 Incorporation of DynaLynk Pharma Pte Ltd, a joint venture with Dynavest to expand manufacturing facility.
|
- Year 2006 Launch of MediLynk Andro Cream For Men (for male vitality) and MediLynk Oestro Cream (for bust firming).
|
- Year 2006 Launch of CosmeLynk Hair Cream For Men (anti-greying).
|
- Year 2006 Development of trans-epidermal SportsLynk Tmax cream (to relieve aches and itch).
|
- Year 2007 Successful completion of Phase II Clinical Trial For MediLynk TGC in Indonesia (at the Faculty of Medicine - University of Indonesia, and the Cipto Mangunkusumo Central Hospital, Jakarta, Indonesia Hospital).
|
- Year 2008 Attained Good Manufacturing Practise (GMP) certification from the Health Sciences Authority (HSA) of Singapore for our pharmaceutical factory, DynaLynk Pharma Pte Ltd.
|
